Data / Form D filings / Allon Therapeutics Inc
Allon Therapeutics Inc: Form D filing
Allon Therapeutics Inc, a biotechnology company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2012. The latest, on May 17, 2012, reports $1.6 million sold of a $2.9 million offering to 2 investors.
Find out what Allon Therapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SUITE 506, 1168 HAMILTON STREET, Vancouver, British Columbia, Canada, V6B 2
- Phone
- (604) 734-5060
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1306079
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 17, 2012 | New notice | $2,927,127 | $1,626,182 | $1,300,945 | 2 | May 1, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MICHAEL J GOLD | Executive Officer | |
| MARTIN A BARKIN | Director | |
| MICHAEL G ALDRIDGE | Director | |
| ILLANA J GOZES | Director | |
| GORDON C McCAULEY | Executive Officer, Director | |
| ANTHONY G PHILLIPS | Director | |
| JAMES J MILLER | Director | |
| MATTHEW J CARLYLE | Executive Officer | |
| FRANK A HOLLER | Director | |
| ALISTAIR H STEWART | Executive Officer | |
| BRUCE H MORIMOTO | Executive Officer |
Every Form D from the week of May 14, 2012 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Allon Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.